Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report

Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease affecting over 71 million people worldwide. An increased incidence of atherothrombotic events [e.g. coronary artery disease (CAD), atrial fibrillation (AF)] has been observed in HCV seropositive patients. On the other hand...

Full description

Bibliographic Details
Main Authors: Mario Enrico Canonico, Giuseppe Damiano Sanna, Roberta Siciliano, Fernando Scudiero, Giovanni Esposito, Guido Parodi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
drug-drug interactions
hepatitis C virus
antiplatelet agents
anticoagulant agents
thrombo-haemorrhagic risk
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.916361/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.916361/full

Similar Items